Ardent Health, Inc.
Filed with the SEC on · accession 0001628280-26-071073
ARDT filed a 10-Q (quarterly report) with the SEC on Nov 5, 2026. Ardent Health, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results and operational updates. The stock moved +22.4% by the first close after the filing.
Ardent Health, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results and operational updates. The filing includes standard financial statements, segment data, and disclosures on revenue, payor mix, and variable interest entities.
Close before
$12.99
Nov 4, 2026
First close after
+22.40%
$15.90
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for ARDT, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ARDT?
Click hereARDT filed a 10-Q (SEC filing). Ardent Health, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results and operational updates. The filing includes standard financial statements, segment data, and disclosures on revenue, payor mix, and variable interest entities.
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
ARDT closed at $12.99 before the filing and $15.90 on Nov 5, 2026 (+22.40%).
Get alerts when ARDT files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days